IDEXX Laboratories, Inc. (IDXX) Stock: Greater Than Its Current Valuation?
BTIG Research has recently initiated IDEXX Laboratories, Inc. (IDXX) stock to Buy rating, as announced on July 25, 2024, according to Finviz. Earlier, on January 30, 2024, Piper Sandler had reduced the stock from a Overweight to Neutral, setting a price target of $525. Exane BNP Paribas also initiated Outperform rating with a price target […]
IDEXX Laboratories, Inc. (IDXX) Stock: More Robust Than the Numbers Suggest?
BTIG Research has recently initiated IDEXX Laboratories, Inc. (IDXX) stock to Buy rating, as announced on July 25, 2024, according to Finviz. Earlier, on January 30, 2024, Piper Sandler had reduced the stock from a Overweight to Neutral, setting a price target of $525. Exane BNP Paribas also initiated Outperform rating with a price target […]
IDEXX Laboratories, Inc. (IDXX) Stock: Greater Than Its Current Valuation?
BTIG Research has recently initiated IDEXX Laboratories, Inc. (IDXX) stock to Buy rating, as announced on July 25, 2024, according to Finviz. Earlier, on January 30, 2024, Piper Sandler had reduced the stock from a Overweight to Neutral, setting a price target of $525. Exane BNP Paribas also initiated Outperform rating with a price target […]
IDEXX Laboratories, Inc. (IDXX) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
BTIG Research has recently initiated IDEXX Laboratories, Inc. (IDXX) stock to Buy rating, as announced on July 25, 2024, according to Finviz. Earlier, on January 30, 2024, Piper Sandler had reduced the stock from a Overweight to Neutral, setting a price target of $525. Exane BNP Paribas also initiated Outperform rating with a price target […]
Idexx Laboratories, Inc. (IDXX) Stock Still Strong Despite Competition
BTIG Research raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock to “a Buy”. The rating was released on July 25, 2024, according to finviz. The research report from Exane BNP Paribas has initiated the stock to Outperform, with a price target set at $602. In their research brief published August 02, 2023, […]
Idexx Laboratories, Inc. (IDXX) Stock is the one stock you should own forever
BTIG Research raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock to “a Buy”. The rating was released on Jul-26-24, according to finviz. The research report from Exane BNP Paribas has initiated the stock to Outperform, with a price target set at $602. In their research brief published August 02, 2023, Atlantic Equities […]
Analysts Rating: Idexx Laboratories, Inc. (NASDAQ:IDXX) Stock Won “a Neutral” Rating From Piper Sandler
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
Idexx Laboratories, Inc. (IDXX) Stock Is Looking Attractive
Piper Sandler raised the price target for the Idexx Laboratories, Inc. (NASDAQ:IDXX) stock from “an Overweight” to “a Neutral”. The rating was released on January 30, 2024, according to finviz. The stock was downgraded by Atlantic Equities, who disclosed in a research note on August 02, 2023, from Overweight to Neutral and set the price […]
